Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/ https://www.ncbi.nlm.nih.gov/pubmed/36415714 http://dx.doi.org/10.1002/ccr3.6621 |
Sumario: | We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement. |
---|